Merck Alleges Infringement Of Antibacterial Drug

Law360, New York (May 2, 2007, 12:00 AM EDT) -- Pharmaceutical giant Merck & Co. Inc. has sued India’s Ranbaxy Laboratories Ltd. for allegedly infringing its patent for the antibacterial drug Primaxin.

In a complaint filed Monday with the U.S. District Court for the District of Delaware, Merck asked that Ranbaxy be enjoined from marketing a generic version of Primaxin in the United States.

The suit was sparked by Ranbaxy's filing of an Abbreviated New Drug Application to market generic imipenem-cilastatin, a drug that it sells in India. Imipenem-cilastatin contains the active ingredients in the drug...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.